Free Papers

Search Title by author or title

Premium intraocular lenses in patients with coexisting retinal diseases

Free Paper Details

First Author: O.Donmez TURKEY

Co Author(s):    H. Kocaoglu   E. Lebe   S. Kaynak              

Abstract Details


To assess the objective and subjective visual outcomes and patients satisfaction following implantation of premium intraocular lenses (IOL) in patients with coexisting retinal diseases.


Retrospective study, Retina Ophthalmic Research Center, Izmir, Turkey


This study included 12 eyes of 14 consecutive patients who underwent cataract surgery and implantation of Acriva Reviol MF, Acriva Trinova and Acriva Trinova Toric IOLs (VSY Biotechnology, Istanbul, Turkey).Clinical charts of patients with coextisting retinal diseases with high intellectual capacity including age related macular degeneration (AMD), diabetes mellitus, history of retinal detachment were reviewd. According to Beckman classification, no disease/normal aging patients with ≤63 micron drusen called droplets were involved. Early visual (best corrected visual acuity, BCVA) and refractive parameters, presence of optic phenomena, posterior capsule opacification, reading speed and visual function test-14 were evaluated at postoperative 6th month.


Twelve patients had dry age related macular degeneration (AMD), one history of pars plana vitrectomy due to retinal detachment, one had dry AMD and glaucoma. Mean age of the patients was 65.6±10 years. Trinova IOL was implanted in 50% of patients, Trinova Toric 18% and Reviol IOL 32%. Mean BCVA was significantly improved from 0.49±0.36 (0.1-1.30) logmar to 0.09±0.14 (0-0.4) logmar (p=0.00). Mean spherical equivalent was -0.6±0.5 (-0.5-1.75) D postoperatively. Reading speed was significantly improved (p=0.04).Half of the patients reported nondisturbing dysphotopsia. Mild posterior capsule opacification was noted in five eyes. Mean score of VF-14 test was 83.2±5.4 (75-98).


Premium IOLs provided satisfactory objective and subjective visual outcomes in this study and may be implanted in appropriately selected cases with coexisting retinal diseases such as before early stage AMD more than 65 years old or non insulin depended and older than 65 years old diabetics followed more than 10 years without macular changes in OCT. Comprehensive ophthalmological examination and detailed counseling of patients are crucial for satisfactory postoperative outcomes.

Financial Disclosure:


Back to Free Papers listing